那他珠单抗正在进行临床实验，结果显示它比以前的治疗剂在阻止多发性硬化症导致的神经细胞损伤方面具有更好的效果。

Natalizumab is being tested in clinical trials and appears to be much better at preventing the nerve cell destruction associated with multiple sclerosis than previous therapies.

youdao

那他珠单抗正在进行临床实验，结果显示它比以前的治疗剂在阻止多发性硬化症导致的神经细胞损伤方面具有更好的效果。

Natalizumab is being tested in clinical trials and appears to be much better at preventing the nerve cell destruction associated with multiple sclerosis than previous therapies.

youdao